bf/NYSE:BIO_icon.jpeg

COM:BIO-RAD

Bio-Rad Laboratories, Inc.

  • Stock

Last Close

325.58

22/11 21:00

Market Cap

8.01B

Beta: -

Volume Today

184.50K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
474.83M
-
486.14M
2.38%
480.61M
1.14%
507.59M
5.61%
559.88M
10.30%
589.57M
5.30%
569.17M
3.46%
588.13M
3.33%
597.25M
1.55%
645.78M
8.13%
749.92M
16.13%
average payables
139.74M
-
138.56M
0.85%
204.43M
47.54%
288.36M
41.06%
301.64M
4.61%
285.64M
5.30%
275.78M
3.45%
324.71M
17.74%
390.63M
20.30%
374.38M
4.16%
236.33M
36.87%
average receivables
410.70M
-
400.15M
2.57%
384.56M
3.90%
381.92M
0.69%
418.60M
9.60%
429.00M
2.48%
392.91M
8.41%
406.05M
3.34%
421.48M
3.80%
459.09M
8.92%
497.78M
8.43%
book value per share
76.50
-
75.67
1.08%
85.33
12.76%
87.87
2.97%
98.81
12.46%
134.59
36.21%
192.84
43.28%
331.90
72.11%
458.15
38.04%
322.82
29.54%
299.26
7.30%
capex per share
-3.98
-
-4.73
18.83%
-3.88
17.81%
-4.81
23.80%
-3.88
19.27%
-4.35
12.09%
-3.30
24.12%
-3.32
0.65%
-4.05
21.86%
-3.83
5.36%
-5.36
39.96%
capex to depreciation
-0.77
-
-0.91
17.85%
-0.86
5.56%
-0.99
15.22%
-0.77
21.84%
-0.94
21.42%
-0.73
21.93%
-0.72
2.43%
-0.90
26.07%
-0.83
7.91%
-0.81
2.06%
capex to operating cash flow
-0.65
-
-0.50
22.93%
-0.61
21.93%
-0.65
7.44%
-1.11
69.42%
-0.45
58.97%
-0.22
52.68%
-0.17
20.10%
-0.18
7.02%
-0.59
219.06%
-0.42
28.82%
capex to revenue
-0.05
-
-0.06
17.70%
-0.06
10.53%
-0.07
21.93%
-0.05
22.14%
-0.06
6.37%
-0.04
24.81%
-0.04
8.83%
-0.04
6.37%
-0.04
1.44%
-0.06
43.98%
cash per share
21.30
-
24.16
13.42%
27.08
12.10%
28.67
5.85%
25.65
10.54%
28.50
11.13%
37.54
31.70%
33.48
10.80%
29.35
12.35%
60.31
105.49%
55.22
8.44%
days of inventory on hand
191.75
-
172.51
10.03%
199.31
15.53%
206.01
3.37%
223.18
8.33%
200.12
10.33%
191.73
4.19%
205.02
6.93%
162.94
20.53%
212.61
30.48%
229.76
8.07%
days payables outstanding
56.81
-
47.11
17.08%
113.94
141.88%
116.35
2.11%
115.12
1.05%
90.58
21.32%
99.36
9.70%
119.38
20.15%
119.28
0.08%
97.49
18.27%
42.04
56.87%
days sales outstanding
72.34
-
63.37
12.39%
70.76
11.65%
65.71
7.13%
78.54
19.53%
62.66
20.22%
62.00
1.05%
60.14
3.00%
52.90
12.04%
64.43
21.80%
68.45
6.23%
debt to assets
0.13
-
0.13
1.09%
0.12
9.97%
0.11
3.94%
0.10
9.77%
0.08
22.99%
0.05
29.98%
0.00
98.03%
0.00
42.87%
0.09
14,236.83%
0.10
12.77%
debt to equity
0.20
-
0.20
0.25%
0.18
12.25%
0.17
4.05%
0.15
11.63%
0.11
26.29%
0.08
30.17%
0.00
98.14%
0.00
43.41%
0.12
15,378.47%
0.14
13.00%
dividend yield
0.00
-
0.35
-
1.57
-
5.44
247.79%
10.61
94.96%
earnings yield
0.02
-
0.03
15.92%
0.03
9.50%
0.01
81.25%
0.02
209.32%
0.05
221.40%
0.16
205.66%
0.22
37.73%
0.19
14.12%
-0.29
253.76%
-0.07
76.67%
enterprise value
3.64B
-
3.50B
3.72%
4.03B
14.88%
5.34B
32.77%
7.13B
33.39%
6.94B
2.70%
10.82B
56.02%
16.70B
54.36%
22.08B
32.18%
13.29B
39.82%
10.43B
21.49%
enterprise value over ebitda
11.05
-
11.20
1.36%
13.00
16.08%
19.56
50.45%
24.66
26.10%
18.92
23.28%
27.75
46.64%
29.12
4.96%
33.97
16.63%
20.00
41.13%
18.11
9.45%
ev to operating cash flow
20.74
-
12.82
38.18%
21.62
68.62%
24.69
14.23%
68.62
177.90%
24.30
64.59%
23.63
2.73%
29.04
22.85%
33.63
15.83%
68.34
103.20%
27.83
59.28%
ev to sales
1.71
-
1.61
5.59%
1.99
23.73%
2.58
29.64%
3.30
27.71%
3.03
8.22%
4.68
54.56%
6.56
40.17%
7.55
15.13%
4.74
37.23%
3.91
17.64%
free cash flow per share
2.16
-
4.74
119.27%
2.50
47.33%
2.54
1.89%
-0.38
114.91%
5.22
1,476.28%
12.04
130.80%
16.00
32.90%
17.96
12.21%
2.70
84.99%
7.47
177.20%
free cash flow yield
0.02
-
0.04
124.82%
0.02
54.21%
0.01
22.49%
-0.00
111.39%
0.02
1,514.51%
0.03
44.84%
0.03
15.64%
0.02
13.43%
0.01
73.03%
0.02
260.99%
graham net net
-0.89
-
2.09
333.80%
3.71
77.65%
4.14
11.82%
2.19
47.19%
-5.04
330.45%
-18.83
273.50%
-49.39
162.24%
-88.14
78.46%
-45.65
48.22%
-40.37
11.56%
graham number
68.44
-
72.38
5.76%
86.25
19.17%
43.46
49.62%
92.75
113.42%
191.42
106.38%
505.67
164.17%
977.17
93.24%
1.21K
23.96%
940.55
22.35%
383.30
59.25%
income quality
2.26
-
3.08
36.41%
1.65
46.48%
7.70
367.37%
0.91
88.23%
0.79
12.65%
0.26
67.08%
0.15
41.95%
0.15
2.30%
-0.05
134.67%
-0.59
997.53%
intangibles to total assets
0.23
-
0.23
2.37%
0.19
15.31%
0.17
13.28%
0.16
4.02%
0.06
61.34%
0.05
16.89%
0.04
25.94%
0.03
10.70%
0.05
61.73%
0.06
9.10%
interest coverage
2.77
-
6.78
145.04%
7.69
13.40%
2.42
68.46%
5.32
119.57%
-4.53
185.17%
9.81
316.32%
18.80
91.67%
315.56
1,578.62%
12.66
95.99%
7.76
38.69%
interest debt per share
17.44
-
15.86
9.06%
15.68
1.15%
15.50
1.13%
15.41
0.63%
15.53
0.80%
15.52
0.07%
1.21
92.23%
0.42
65.12%
41.51
9,763.03%
43.83
5.60%
inventory turnover
1.90
-
2.12
11.15%
1.83
13.44%
1.77
3.26%
1.64
7.69%
1.82
11.52%
1.90
4.38%
1.78
6.48%
2.24
25.83%
1.72
23.36%
1.59
7.47%
invested capital
0.20
-
0.20
0.25%
0.18
12.25%
0.17
4.05%
0.15
11.63%
0.11
26.29%
0.08
30.17%
0.00
98.14%
0.00
43.41%
0.12
15,378.47%
0.14
13.00%
market cap
3.53B
-
3.48B
1.48%
4.05B
16.25%
5.37B
32.60%
7.08B
31.89%
6.93B
2.11%
11.04B
59.38%
17.35B
57.14%
22.54B
29.89%
12.52B
44.43%
9.43B
24.70%
net current asset value
545.79M
-
560.24M
2.65%
556.56M
0.66%
580.78M
4.35%
635.45M
9.41%
436.51M
31.31%
-73.65M
116.87%
-952.84M
1,193.80%
-2.12B
122.45%
-728.44M
65.63%
-509.61M
30.04%
net debt to ebitda
0.32
-
0.07
77.40%
-0.07
195.80%
-0.08
14.37%
0.18
322.50%
0.02
87.82%
-0.57
2,727.06%
-1.13
99.48%
-0.71
37.40%
1.15
262.54%
1.74
51.24%
net income per share
2.72
-
3.08
13.06%
3.87
25.94%
0.96
75.35%
3.87
305.01%
12.10
212.71%
58.93
387.06%
127.86
116.97%
142.33
11.31%
-121.79
185.57%
-21.82
82.08%
operating cash flow per share
6.14
-
9.47
54.19%
6.38
32.59%
7.35
15.23%
3.50
52.35%
9.57
173.15%
15.34
60.35%
19.33
25.96%
22.01
13.87%
6.53
70.34%
12.84
96.63%
payables turnover
6.43
-
7.75
20.60%
3.20
58.66%
3.14
2.07%
3.17
1.06%
4.03
27.10%
3.67
8.84%
3.06
16.77%
3.06
0.08%
3.74
22.36%
8.68
131.87%
receivables turnover
5.05
-
5.76
14.14%
5.16
10.44%
5.55
7.68%
4.65
16.34%
5.83
25.35%
5.89
1.06%
6.07
3.10%
6.90
13.69%
5.67
17.90%
5.33
5.87%
research and ddevelopement to revenue
0.10
-
0.10
2.41%
0.10
5.67%
0.10
4.17%
0.12
16.41%
0.09
24.93%
0.09
0.82%
0.09
1.51%
0.09
4.42%
0.09
1.38%
0.08
7.33%
return on tangible assets
0.03
-
0.03
15.02%
0.04
9.69%
0.01
76.76%
0.03
264.80%
0.07
114.90%
0.23
237.13%
0.30
31.77%
0.25
18.93%
-0.28
214.97%
-0.06
80.61%
revenue per share
74.61
-
75.32
0.96%
69.19
8.14%
70.25
1.53%
72.84
3.69%
76.76
5.37%
77.46
0.92%
85.52
10.40%
97.97
14.56%
94.08
3.97%
91.45
2.79%
roe
0.04
-
0.04
14.29%
0.05
11.69%
0.01
76.06%
0.04
260.13%
0.09
129.58%
0.31
239.94%
0.39
26.07%
0.31
19.36%
-0.38
221.44%
-0.07
80.67%
roic
0.04
-
0.04
13.57%
0.04
14.31%
0.01
73.03%
0.04
241.29%
-0.02
142.67%
0.03
260.42%
0.03
13.19%
0.03
12.75%
0.03
23.04%
0.03
16.16%
sales general and administrative to revenue
0.37
-
0.37
0.70%
0.38
1.55%
0.39
4.66%
0.37
5.17%
0.36
2.66%
shareholders equity per share
76.50
-
75.67
1.08%
85.33
12.76%
87.87
2.97%
98.81
12.46%
134.59
36.21%
192.84
43.28%
331.90
72.11%
458.15
38.04%
322.82
29.54%
299.26
7.30%
stock based compensation to revenue
0.01
-
0.01
6.64%
0.01
22.89%
0.01
13.15%
0.01
13.72%
0.01
12.06%
0.02
26.86%
0.02
6.11%
0.02
7.20%
0.02
24.05%
0.02
5.59%
tangible asset value
1.40B
-
1.43B
1.98%
1.78B
24.47%
1.95B
9.41%
2.25B
15.51%
3.67B
63.14%
5.35B
45.62%
9.39B
75.64%
13.07B
39.17%
8.88B
32.06%
8.01B
9.80%
tangible book value per share
49.07
-
49.54
0.95%
61.01
23.15%
66.17
8.46%
75.88
14.67%
123.03
62.15%
179.12
45.58%
315.39
76.08%
438.00
38.87%
298.02
31.96%
274.13
8.02%
working capital
1.26B
-
1.27B
0.73%
1.34B
5.25%
1.37B
2.77%
1.47B
7.37%
1.58B
6.82%
1.27B
19.07%
1.51B
18.33%
1.31B
13.27%
2.59B
97.93%
2.53B
2.46%

All numbers in (except ratios and percentages)